Market Overview

JP Morgan Maintains Overweight on Covidien plc., Raises PT to $66.00

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for COV

DateFirmActionFromTo
Nov 2014JefferiesMaintainsBuy
Oct 2014Morgan StanleyDowngradesOverweightEqualweight
Jul 2014CitigroupMaintainsBuy

View More Analyst Ratings for COV
View the Latest Analyst Ratings

Posted-In: News Price Target Analyst Ratings

 

Related Articles (COV)

Around the Web, We're Loving...

Get Benzinga's Newsletters